The C3a receptor antagonist SB 290157 has agonist activity

Immunology Letters

Volumn 100, Issue 2, 2005, Pages 139-145

  Mathieu, Marie Claude ^a   Sawyer, Nicole ^a   Greig, Gillian M ^a   Hamel, Martine ^a   Kargman, Stacia ^a   Ducharme, Yves ^a   Lau, Cheuk K ^a   Friesen, Richard W ^a   O'Neill, Gary P ^a   Gervais, Francois G ^a   Therien, Alex G ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

Anaphylatoxin; Asthma; GPCR

Indexed keywords

BETA LACTAMASE; CALCIUM; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C3A RECEPTOR ANTAGONIST; RECEPTOR BLOCKING AGENT; SB 290157; UNCLASSIFIED DRUG;

AGONIST; ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CELL ASSAY; CELL STRAIN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME ASSAY; ENZYME RELEASE; GUINEA PIG; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOLECULE; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; THROMBOCYTE;

ANIMALS; ARGININE; BENZHYDRYL COMPOUNDS; BETA-LACTAMASES; BINDING, COMPETITIVE; BLOOD PLATELETS; CALCIUM; CELL LINE, TUMOR; CELL MEMBRANE; CHO CELLS; COMPLEMENT C3A; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MACACA FASCICULARIS; MEMBRANE PROTEINS; RATS; RECEPTORS, COMPLEMENT; TRANSFECTION; U937 CELLS;

EID: 24344461844     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.03.003     Document Type: Article

References (33)

1. N.P. Gerard, and C. Gerard Complement in allergy and asthma Curr Opin Immunol 14 2002 705 708
2. H. Hawlisch, M. Wills-Karp, C.L. Karp, and J. Kohl The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma Mol Immunol 41 2004 123 131
3. R.S. Ames, Y. Li, H.M. Sarau, P. Nuthulaganti, J.J. Foley, and C. Ellis Molecular cloning and characterization of the human anaphylatoxin C3a receptor J Biol Chem 271 1996 20231 20234
4. T. Crass, U. Raffetseder, U. Martin, M. Grove, A. Klos, and J. Kohl Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells Eur J Immunol 26 1996 1944 1950
5. J. Norgauer, G. Dobos, E. Kownatzki, C. Dahinden, R. Burger, and R. Kupper Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein Eur J Biochem 217 1993 289 294
6. A. Roglic, E.R. Prossnitz, S.L. Cavanagh, Z. Pan, A. Zou, and R.D. Ye cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure Biochim Biophys Acta 1305 1996 39 43
7. I.U. Schraufstatter, K. Trieu, L. Sikora, P. Sriramarao, and R. DiScipio Complement c3a and c5a induce different signal transduction cascades in endothelial cells J Immunol 169 2002 2102 2110
8. S.M. Drouin, D.B. Corry, T.J. Hollman, J. Kildsgaard, and R.A. Wetsel Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy J Immunol 169 2002 5926 5933
9. S.M. Drouin, D.B. Corry, J. Kildsgaard, and R.A. Wetsel Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy J Immunol 167 2001 4141 4145
10. A.A. Humbles, B. Lu, C.A. Nilsson, C. Lilly, E. Israel, and Y. Fujiwara A role for the C3a anaphylatoxin receptor in the effector phase of asthma Nature 406 2000 998 1001
11. A.C. La Flamme, A.S. MacDonald, C.R. Huxtable, M. Carroll, and E.J. Pearce Lack of C3 affects Th2 response development and the sequelae of chemotherapy in schistosomiasis J Immunol 170 2003 470 476
12. D.M. Walters, P.N. Breysse, B. Schofield, and M. Wills-Karp Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness Am J Respir Cell Mol Biol 27 2002 413 418
13. N. Zimmermann, N.E. King, J. Laporte, M. Yang, A. Mishra, and S.M. Pope Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis J Clin Invest 111 2003 1863 1874
14. S.M. Drouin, J. Kildsgaard, J. Haviland, J. Zabner, H.P. Jia, and P.B. McCray Jr. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma J Immunol 166 2001 2025 2032
15. N. Krug, T. Tschernig, V.J. Erpenbeck, J.M. Hohlfeld, and J. Kohl Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma Am J Respir Crit Care Med 164 2001 1841 1843
16. Y. Nakano, S. Morita, A. Kawamoto, T. Suda, K. Chida, and H. Nakamura Elevated complement C3a in plasma from patients with severe acute asthma J Allergy Clin Immunol 112 2003 525 530
17. K. Hasegawa, M. Tamari, C. Shao, M. Shimizu, N. Takahashi, and X.Q. Mao Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma Hum Genet 115 2004 295 301
18. N. Srivastava, S.P. Gupta, and L.M. Srivastava Association between C3 complement types and bronchial asthma Hum Hered 35 1985 263 264
19. R.S. Ames, D. Lee, J.J. Foley, A.J. Jurewicz, M.A. Tornetta, and W. Bautsch Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models J Immunol 166 2001 6341 6348
20. R. Baelder, B. Fuchs, W. Bautsch, J. Zwirner, J. Kohl, and H.G. Hoymann Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation J Immunol 174 2005 783 789
21. J. Godau, T. Heller, H. Hawlisch, M. Trappe, E. Howells, and J. Best C5a initiates the inflammatory cascade in immune complex peritonitis J Immunol 173 2004 3437 3445
22. T.E. Mollnes, O.L. Brekke, M. Fung, H. Fure, D. Christiansen, and G. Bergseth Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation Blood 100 2002 1869 1877
23. L.M. Proctor, T.V. Arumugam, I. Shiels, R.C. Reid, D.P. Fairlie, and S.M. Taylor Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury Br J Pharmacol 142 2004 756 764
24. J. Ratajczak, R. Reca, M. Kucia, M. Majka, D.J. Allendorf, and J.T. Baran Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow Blood 103 2004 2071 2078
25. L.A. Goldman, E.C. Cutrone, S.V. Kotenko, C.D. Krause, and J.A. Langer Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression Biotechniques 21 1996 1013 1015
26. N.P. Gerard, and C. Gerard Construction and expression of a novel recombinant anaphylatoxin, C5a-N19, as a probe for the human C5a receptor Biochemistry 29 1990 9274 9281
27. A. Klos, S. Bank, C. Gietz, W. Bautsch, J. Kohl, and M. Burg C3a receptor on dibutyryl-cAMP-differentiated U937 cells and human neutrophils: the human C3a receptor characterized by functional responses and 125I-C3a binding Biochemistry 31 1992 11274 11282
28. B. Zanker, H. Rasokat, U. Hadding, and D. Bitter-Suermann C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets Agents Actions Suppl 11 1982 147 157
29. D. Hoyer, and H.W. Boddeke Partial agonists, full agonists, antagonists: dilemmas of definition Trends Pharmacol Sci 14 1993 270 275
30. Y. Fukuoka, and T.E. Hugli Demonstration of a specific C3a receptor on guinea pig platelets J Immunol 140 1988 3496 3501
31. R. Gerardy-Schahn, D. Ambrosius, D. Saunders, M. Casaretto, C. Mittler, and G. Karwarth Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes Eur J Immunol 19 1989 1095 1102
32. T. Hoffmann, E.C. Bottger, H.P. Baum, M. Messner, U. Hadding, and D. Bitter-Suermann In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model Clin Exp Immunol 71 1988 486 492
33. J.F. Regal, and A. Klos Minor role of the C3a receptor in systemic anaphylaxis in the guinea pig Immunopharmacology 46 2000 15 28